SEC Form 4 · accession 0001437749-18-004233
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Tobin
Director
Period of report
Mar 6, 2018
Accepted (ET)
Mar 8, 2018 · 6:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 6, 2018 | M | 5,000 | $5.77 | A | 49,459 | D | |
| Common Stock | Mar 6, 2018 | F | 2,177 | $13.25 | D | 47,282 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonstatutory Stock Option (Right to Buy) | $5.77 | Mar 6, 2018 | M | 5,000 | D | May 24, 2011 | May 23, 2018 | Common Stock | 5,000 | 5,000 | D |